Aurinia Pharmaceuticals (AUPH) has released an update.
Aurinia Pharmaceuticals Inc. is set to participate in the Bloom Burton & Co. Healthcare Investor Conference in Toronto, where it will present on April 16 from 4:00 to 4:30 PM Eastern Time, with a live webcast available online. The company, known for its work in autoimmune diseases and introducing the first FDA-approved oral therapy for lupus nephritis, aims to connect with investors through one-on-one meetings and its presentation.
For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.
